Exchange Traded Instrument · DE000AMC0B38 ↗

ARQuant Long Short
Momentum ETI

A systematic, fully algorithmic long/short US equity strategy blended with an ETF overlay — EUR-hedged and listed on Börse Stuttgart. ETI launched May 2026.

Simulated performance: figures below are based on simulation (Mar 2018 – Apr 2026). Actual ETI track record starts May 2026.
16.30%
Annualised Return
Simulated · after fees · EUR
1.14
Sharpe Ratio
Simulated (Mar 2018 – Apr 2026)
18.78%
Max Drawdown
Simulated period
+248%
Cumulative Return
Mar 2018 – Apr 2026 · EUR · simulated
ISIN
EUR
Denomination
USD
Base Currency
May 2026
ETI Inception
Exchange
Issuer
4.50% + 20%
Ongoing + Perf. Fee
iShares S&P 500 EUR Hdg
Benchmark

Simulated Historical Performance
Consistent Returns Across Market Cycles
⚠ Simulated data — not actual ETI performance. Figures cover March 2018 to April 2026 and are based on: (1) actual ARQuant strategy returns; (2) actual SPY ETF as overlay at 30% of NAV; (3) USD returns EUR-hedged using 1-month forward EUR/USD rates derived from monthly USD and EUR interest rates; (4) adjusted for interest on margin loans and fees. The ETI (DE000AMC0B38) was incepted in May 2026. Benchmark: iShares S&P 500 EUR Hedged UCITS ETF (Acc) · ISIN IE00B3ZW0K18.

All years positive in the simulated period. EUR-denominated, after fees.

Year JanFebMarAprMayJun JulAugSepOctNovDec YTD

Source: ARQuant Management. Simulation based on actual ARQuant strategy returns and actual SPY performance (100% + 30% of NAV respectively), EUR-hedged using month-end 1-month forward rates. Past performance is not a reliable indicator of future results.

Risk & Return Metrics
Key Performance Statistics · After Fees

Annualised figures across multiple time horizons, EUR-denominated.

Fees
Cost Structure

01 — One-off costs

Until assets under management (AUM) reaches €2.5m, a 1% fee applies to each ETI purchase or sale amount. Once AUM exceeds this threshold, the rate steps down to 0.5% — improving liquidity economics for all investors.

02 — Total ongoing charges

Fixed annual

All-in fixed costs up to €15,350

Variable annual

Issuer management 0.20% on AUM

All-in cap

4.5%

p.a. · per KID

excl. one-off costs
and performance fee

AUM

€500k

Total ongoing charges

3.23%

Total ongoing charges

€16,150

per year

€500k
3.23%

03 — Performance fee

20% of positive NAV change above the high-water mark, calculated and charged quarterly. No fee is charged unless the portfolio exceeds its previous peak. Not subject to the 4.5% p.a. all-in cap.

04 — Why this structure works for investors

📉

Costs fall as AUM grows

Every additional subscription spreads fixed costs across a larger investor base, driving the effective expense ratio lower for all. At €5m AUM, ARQuant ETI reaches 0.46% p.a. — below the 0.50%–1.50% p.a. typical of actively managed ETFs.

🛡️

Manager has skin in the game

The Delegated Manager (ARQuant Management Limited) commits €100,000 of their own capital before any external investor enters, and will be the last to redeem. They absorb the highest cost burden at launch — demonstrating conviction, not just collecting fees.

📈

Institutional economics at €2.5m+

Above €2.5m AUM the ongoing charges drop below 0.8% p.a. — comparable to actively managed long/short equity ETFs — while entry and exit fees also step down from 1.0% to 0.5%, improving liquidity economics for all investors.

Investment Strategy
How the Portfolio is Constructed

The underlying portfolio has two components running simultaneously, both managed by ARQuant Management Limited (Delegated Manager). Benchmark: iShares S&P 500 EUR Hedged UCITS ETF (Acc) · ISIN IE00B3ZW0K18.

⚙️

ARQuant Proprietary Strategy

A fully automated, market-neutral Quantitative Long/Short Equity strategy active since March 2018. Constitutes 100% of portfolio notional at all times.

  • 32 independent predictors, re-optimised every 15 minutes
  • Universe: all liquid US-listed stocks & ETFs (up to 100 candidates quarterly)
  • Tradeable portfolio: 15–25 stocks, rebalanced bi-weekly
  • Average holding period: 3–5 business days
  • Kelly criterion-based leverage, gross exposure capped at 300% NAV
  • Stop-loss: drawdown monitored hourly vs high-water mark
📊

ETF Overlay

A supplementary long-side allocation to actively managed long/short US equity ETFs, providing additional diversification and market participation.

  • Approved basket: CLSE, FFLS, LBAY, SPY — basket may be extended
  • Initial deployment: CLSE only at inception
  • Target allocation: 30% of AUM (fixed until AUM exceeds USD 500M)
  • Dynamic range of 30–100% once AUM threshold is reached
  • Daily rebalancing; trade triggered when deviation exceeds 5% of target
  • EUR/USD hedge via Micro CME futures, adjusted when >2.5% or €12,500 off target
How to Invest
Three Steps to Access the ETI

The certificate is listed on Börse Stuttgart and available through most brokers that provide access to European exchange-traded products.

1

Read the Key Documents

Download and review the KID and Final Terms from the Documents section below or from the iMaps ETI AG website before investing.

2

Access via Your Broker

Purchase the certificate through any broker with access to Börse Stuttgart — including Interactive Brokers, Swissquote, or your regular bank or broker.

3

Search by ISIN

Use ISIN DE000AMC0B38 to find and trade the instrument. For institutional or large ticket enquiries, contact us directly below.

Intended retail investor

The product is intended for private clients who pursue the objective of general asset formation / asset optimization and have a medium to long-term investment horizon. This product is a product for investors with advanced knowledge and / or experience with financial products. The investor may bear losses up to the total loss of the capital invested and attaches no importance to a capital protection.

Distribution & Eligibility
ETI is Eligible For
🌍

Retail Public Offering

Germany, France, Italy, Spain, Cyprus and Switzerland.

🌐

Professional & Qualified Investors

Public Offering to Professional & Qualified Investors in the European Union, United Kingdom, Norway, and Iceland.

🌏

Private Placement

With accredited investors in United Kingdom, Dubai, Singapore, Hong Kong and most other Asian jurisdictions.

Legal Documents
Download Centre

All regulatory disclosure documents are available below. Investors should read the applicable Key Information Document (KID) and offering documentation relevant to their jurisdiction before making any investment decision.

Investment Manager
iMaps ETI AG

iMaps ETI AG is a company duly registered under the laws of Liechtenstein. The company is authorised to issue derivative securities to the public in the European Economic Area as well as in Switzerland under an Issuance Programme approved by the Financial Markets Authority in Liechtenstein. The company is further authorised to provide investment management and any other financial services to its parent company, its subsidiaries as well as to any subsidiary of its parent company.

Visit website ↗
Delegated Manager
ARQuant Management Limited

ARQuant Management Limited is authorised and regulated by the Financial Conduct Authority (FRN 947270). Registered in England & Wales, Company No. 13034143. For full team profiles, track record and strategy details, visit the firm's website.

Visit website ↗
Contact
Get in Touch

Please direct your enquiry to the relevant party below.

📋

Enquire about the ETI

For questions about the certificate structure, issuance, listing, KID, or investing in DE000AMC0B38, contact the Issuer directly.

IssueriMaps ETI AG
⚙️

Enquire about the Underlying Strategy

For questions about the ARQuant investment strategy, performance, or the Delegated Investment Manager, contact ARQuant directly.

ManagerARQuant Management Limited
Disclosure & Disclaimer

Information presented here should be read as an introduction to the base prospectus of the Issuer of the ETI Securities dated 3rd April 2025 (the "Base Prospectus"). This Base Prospectus has been approved by the Liechtenstein Financial Market Authority (the "FMA"), as the competent authority in Liechtenstein under Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the "Prospectus Regulation"). The contact details of the FMA are: Landstrasse 109, Postfach 279, 9490 Vaduz, Liechtenstein; Telephone: +423 236 73 73; Fax: +423 236 72 38; e-mail: info@fma-li.li.

Information about Investment Manager
iMaps ETI AG acts as the Investment Manager and Issuer of the ETI Securities.

Information about Delegated Manager
ARQuant Management Limited (ARQuant or the Firm) is a private company incorporated in England and Wales under the company number 13034143, with its registered office at 167-169 Great Portland Street, Fifth Floor, London, W1W 5PF. ARQuant Management Limited is authorised and regulated by the Financial Conduct Authority (the "FCA") under reference number: 947270. ARQuant Management Limited acts as the Delegated Investment Manager of the Portfolio in relation to the ETI Securities.

Simulated performance
All performance figures shown cover March 2018 to April 2026 and represent simulated results, not actual ETI performance. The ETI (DE000AMC0B38) was incepted in May 2026. Simulation is based on actual historical returns of the ARQuant strategy and actual SPY ETF returns (at 100% and 30% of NAV respectively), with USD returns EUR-hedged using 1-month forward EUR/USD rates derived from monthly interest rates, and adjusted for margin loan interest and applicable fees and commissions. Past performance is not a guarantee of future results. The information contained in this marketing material is not investment research. Some information has been obtained from public sources believed to be reliable, but accuracy, completeness and currency cannot be guaranteed.

Marketing Restrictions
This page constitutes a marketing communication and is not a substitute for the Key Information Document (KID) required under PRIIPs Regulation, or for the Base Prospectus dated 3 April 2025 approved by the Liechtenstein Financial Market Authority (FMA). Read both before investing at the Issuer's website (imaps-capital.com). The prospectus is available free of charge on the Issuer's website https://imaps-capital.com.

This page does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any investment decision should be made solely on the basis of the approved prospectus, which contains detailed information about the ETI Securities, including risks, charges, and expenses. Investors are advised to consult professional advisors before making any investment.

The release and distribution of marketing material and other information relating to securities in certain jurisdictions may be restricted by law, and it must not be relied upon if inaccurate, misleading, or inconsistent with the prospectus. Unless expressly stated to the contrary, this material is intended only for persons who are permitted recipients of this material in the jurisdiction in which the recipient of this material is or belongs. Failure to comply with such restrictions may constitute a violation of the securities laws of that jurisdiction.